Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01055197 · ClinicalTrials.gov registry record · Phase 2
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 97
- Enrollment target
NCT01055197 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 97 participants.
The verdict
NCT01055197, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 97 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high energy x-rays to kill tumor cells. This may be an effective treatment for extensive stage small cell lung cancer. PURPOSE: This randomized phase II trial is comparing how well radiation therapy to the brain works when given with or without radiation therapy to other areas of the body in treating patients with extensive stage small cell lung cancer.
Interventions
- RADIATION Radiation Therapy
- RADIATION Prophylactic Cranial Irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2010-03 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01055197
The ClinicalTrials.gov registry entry for NCT01055197 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Radiation Therapy is the first listed.
NCT01055197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01055197 about?
NCT01055197 is a clinical study titled "Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer". RATIONALE: Radiation therapy uses high energy x-rays to kill tumor cells. This may be an effective treatment for extensive stage small cell lung cancer. PURPOSE: This randomized phase II trial is comparing how well radiation therapy to the brain works when given with or without radiation therapy to...
What is the current status of trial NCT01055197?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 97 participants. The study started on 2010-03. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01055197?
The interventions under investigation include: Radiation Therapy (RADIATION), Prophylactic Cranial Irradiation (RADIATION).
Who is sponsoring clinical trial NCT01055197?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.